Nishinomiya, Japan

Masao Isono

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masao Isono. Retrieved from https://idiyas.com/inventor/masao-isono

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Masao Isono

Introduction: Masao Isono is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of enzyme inhibitors. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents: Masao Isono holds a patent for plasminostreptin, an enzyme inhibitor. The patent details a process for producing plasminostreptin by cultivating a Streptomyces microorganism. This innovative method highlights his expertise in microbiology and enzymology.

Career Highlights: Isono is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His role at Takeda has allowed him to work on groundbreaking research and development projects. His contributions have been instrumental in advancing the company's portfolio in biopharmaceuticals.

Collaborations: Masao Isono has collaborated with esteemed colleagues, including Atsushi Kakinuma and Hiromu Sugino. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion: Masao Isono's work exemplifies the spirit of innovation in the field of biochemistry. His patent for plasminostreptin and his collaborations with other professionals underscore the importance of teamwork in scientific advancements. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…